Patent ID: 11970502
Assignee: ENANTA PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 1:
2. The compound of claim 1, wherein Z is, , wherein A is selected from the group consisting of —R15, —OR15, —NR13R14, and —C(O)NR3R14; R15 is selected from the group consisting of optionally substituted —C1-C8 alkyl, optionally substituted —C2-C8 alkenyl, optionally substituted —C2-C8 alkynyl, optionally substituted —C3-C8 cycloalkyl, optionally substituted 3- to 8-membered heterocycloalkyl, optionally substituted aryl, optionally substituted arylalkyl, optionally substituted heteroaryl, and optionally substituted heteroarylalkyl; and R13, R14, R15, and R21 are as defined in claim 1.